Overview
Description
Sonova Holding AG engages in the development and production of hearing care solutions. It operates through the Hearing Instruments and Cochlear Implants business segments. The Hearing Instruments segment includes the activities related to the design, development, production, distribution, and servicing of hearing instruments and related products. The Cochlear Implants segment involves the activities relevant to the design, development, production, distribution, and servicing of hearing implants and related products. The firm offers its products under the brands Phonak, Unitron, Hansaton, Connect Hearing, Boots Hearingcare, AudioNova, Geers, and Advanced Bionics. The company was founded in 1947 and is headquartered in Staefa, Switzerland.
Healthcare Healthcare Equipment Other Medical Devices Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 15,574 m |
| EPS, EUR | - |
| P/B ratio | 5.6 |
| P/E ratio | 33.8 |
| Dividend yield | 1.92% |
Income statement (2025)
| Revenue, EUR | 3,880 m |
| Net income, EUR | 578 m |
| Profit margin | 14.90% |
What ETF is Sonova Holding AG in?
There are 44 ETFs which contain Sonova Holding AG. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sonova Holding AG is the iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
